1. Home
  2. FOXX vs FEMY Comparison

FOXX vs FEMY Comparison

Compare FOXX & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Foxx Development Holdings Inc.

FOXX

Foxx Development Holdings Inc.

HOLD

Current Price

$4.74

Market Cap

34.0M

Sector

N/A

ML Signal

HOLD

Logo Femasys Inc.

FEMY

Femasys Inc.

HOLD

Current Price

$0.49

Market Cap

37.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOXX
FEMY
Founded
2017
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.0M
37.2M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
FOXX
FEMY
Price
$4.74
$0.49
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$6.83
AVG Volume (30 Days)
13.2K
934.7K
Earning Date
02-13-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$62,266,756.00
$2,061,502.00
Revenue This Year
N/A
$64.02
Revenue Next Year
N/A
$147.19
P/E Ratio
N/A
N/A
Revenue Growth
44.85
63.53
52 Week Low
$1.71
$0.31
52 Week High
$8.88
$1.80

Technical Indicators

Market Signals
Indicator
FOXX
FEMY
Relative Strength Index (RSI) 55.66 38.03
Support Level $4.66 $0.47
Resistance Level $5.15 $0.53
Average True Range (ATR) 0.31 0.04
MACD 0.02 0.00
Stochastic Oscillator 70.34 21.02

Price Performance

Historical Comparison
FOXX
FEMY

About FOXX Foxx Development Holdings Inc.

Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals. The company's current revenue stream is derived from the sales of tablets and smartphones.

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Share on Social Networks: